DAFNA Capital Management LLC 13F holdings, Q2 2025
Holdings as of June 30, 2025 · filings on SEC EDGAR · latest filing →
DAFNA Capital Management LLC disclosed 76 US equity positions worth $362.3m in its Q2 2025 13F filing. The largest position was XBI at 9.5% of the reported book, followed by STXS and RVMD. Against the Q1 2025 filing, it opened 1 new position, added to 18 and reduced 11 among the top 50 holdings.
What did DAFNA Capital Management LLC own in Q2 2025? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q1 2025 |
|---|---|---|---|---|---|---|---|
| 1 | XBI SPDR S&P BIOTECH ETF | 9.5% | $34.5m | 415,505 | 3% | added | |
| 2 | STXS STEREOTAXIS INC | 8.0% | $29.0m | 13,680,554 | 0% | held | |
| 3 | RVMD REVOLUTION MEDICINES INC | Healthcare | 6.9% | $24.9m | 677,176 | 3% | added |
| 4 | 2655787D BLUEPRINT MEDICINES CORP | 6.0% | $21.6m | 168,763 | 11% | added | |
| 5 | MERUS BV | 5.8% | $21.0m | 398,804 | -14% | reduced | |
| 6 | ATRC ATRICURE INC | Healthcare | 5.4% | $19.4m | 592,273 | 0% | held |
| 7 | CYTK CYTOKINETICS INC | Healthcare | 3.6% | $13.2m | 398,100 | 0% | held |
| 8 | IDYA IDEAYA BIOSCIENCES INC | Healthcare | 3.6% | $13.0m | 619,090 | 5% | added |
| 9 | IBB ISHARES NASDAQ BIOTECH INDX | 3.6% | $13.0m | 102,500 | 0% | held | |
| 10 | ASND ASCENDIS PHARMA A/S | Healthcare | 3.5% | $12.5m | 72,677 | -10% | reduced |
| 11 | XENE XENON PHARMACEUTICALS INC | Healthcare | 2.5% | $9.0m | 287,939 | 5% | added |
| 12 | NBIX NEUROCRINE BIOSCIENCES INC | Healthcare | 2.5% | $8.9m | 70,615 | -1% | reduced |
| 13 | AXGN AXOGEN INC | Healthcare | 2.2% | $8.0m | 741,782 | 9% | added |
| 14 | 4XC1 KALVISTA PHARMACEUTICALS INC | 1.8% | $6.6m | 581,757 | -23% | reduced | |
| 15 | DXCM DEXCOM INC | Healthcare | 1.6% | $5.7m | 65,552 | 0% | held |
| 16 | DAWNGBX DAY ONE BIOPHARMACEUTICALS I | 1.6% | $5.7m | 879,163 | 20% | added | |
| 17 | STOK STOKE THERAPEUTICS INC | Healthcare | 1.6% | $5.7m | 501,972 | 13% | added |
| 18 | TNDM TANDEM DIABETES CARE INC | Healthcare | 1.5% | $5.5m | 294,208 | 0% | held |
| 19 | RCUS ARCUS BIOSCIENCES INC | Healthcare | 1.4% | $5.1m | 627,626 | 0% | held |
| 20 | SNDX SYNDAX PHARMACEUTICALS INC | Healthcare | 1.4% | $5.1m | 543,602 | -0% | held |
| 21 | MLYS MINERALYS THERAPEUTICS INC | Healthcare | 1.4% | $5.0m | 371,523 | 20% | added |
| 22 | ASND ASCENDIS PHARMA A/S | 1.4% | $5.0m | 4,000,000 | 0% | held | |
| 23 | URGN UROGEN PHARMA LTD | Healthcare | 1.3% | $4.8m | 349,515 | -29% | reduced |
| 24 | INGN INOGEN INC | Healthcare | 1.2% | $4.3m | 605,625 | 32% | added |
| 25 | LKFT GALAPAGOS NV | Healthcare | 1.0% | $3.6m | 130,175 | 0% | held |
| 26 | BHVN BIOHAVEN LTD | Healthcare | 0.9% | $3.3m | 235,235 | 7% | added |
| 27 | PROQR THERAPEUTICS N V | 0.9% | $3.2m | 1,567,561 | 0% | held | |
| 28 | EWTX EDGEWISE THERAPEUTICS INC | 0.9% | $3.1m | 238,140 | 30% | added | |
| 29 | PODD INSULET CORP | Healthcare | 0.9% | $3.1m | 9,900 | -17% | reduced |
| 30 | IMVT IMMUNOVANT INC | Healthcare | 0.8% | $3.1m | 191,493 | 13% | added |
| 31 | ALKS ALKERMES PLC | Healthcare | 0.8% | $3.0m | 103,748 | 10% | added |
| 32 | BCAX BICARA THERAPEUTICS INC | 0.8% | $2.9m | 317,001 | 50% | added | |
| 33 | TELA TELA BIO INC | 0.8% | $2.8m | 1,441,029 | 0% | held | |
| 34 | KURA KURA ONCOLOGY INC | Healthcare | 0.7% | $2.7m | 463,368 | 0% | held |
| 35 | DNLI DENALI THERAPEUTICS INC | Healthcare | 0.7% | $2.4m | 168,500 | 32% | added |
| 36 | CMPS COMPASS PATHWAYS PLC | Healthcare | 0.6% | $2.3m | 811,046 | 14% | added |
| 37 | ALGN ALIGN TECHNOLOGY INC | Healthcare | 0.6% | $2.1m | 11,000 | 0% | held |
| 38 | BCRX BIOCRYST PHARMACEUTICALS INC | Healthcare | 0.5% | $2.0m | 218,255 | -61% | reduced |
| 39 | CATBUSD ASTRIA THERAPEUTICS INC | 0.5% | $1.7m | 324,775 | 3% | added | |
| 40 | KROS KEROS THERAPEUTICS INC | Healthcare | 0.5% | $1.7m | 130,316 | 0% | held |
| 41 | VKTX VIKING THERAPEUTICS INC | Healthcare | 0.5% | $1.7m | 64,516 | 0% | held |
| 42 | ARAY ACCURAY INC | Healthcare | 0.5% | $1.7m | 1,222,358 | 0% | held |
| 43 | BWAY BRAINSWAY LTD | 0.5% | $1.7m | 127,151 | -19% | reduced | |
| 44 | ALLO ALLOGENE THERAPEUTICS INC | Healthcare | 0.4% | $1.6m | 1,380,118 | 0% | held |
| 45 | LXEO LEXEO THERAPEUTICS INC | Healthcare | 0.4% | $1.5m | 378,083 | 0% | held |
| 46 | FHTX FOGHORN THERAPEUTICS INC | Healthcare | 0.4% | $1.4m | 300,452 | -1% | reduced |
| 47 | 2662247D ITEOS THERAPEUTICS INC | 0.4% | $1.4m | 140,847 | -34% | reduced | |
| 48 | ORIC ORIC PHARMACEUTICALS INC | Healthcare | 0.4% | $1.4m | 135,271 | -44% | reduced |
| 49 | CMPX COMPASS THERAPEUTICS INC | 0.4% | $1.4m | 526,660 | – | new | |
| 50 | IMTX IMMATICS NV | Healthcare | 0.4% | $1.3m | 245,000 | 0% | held |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.